Striders Impex IPO Subscription Status

Striders Impex IPO subscription started on Wednesday February 26, 2026 and will close on March 2, 2026. Striders Impex IPO to raise around ₹36 crores via IPO. The retail quota is 35%, QIB is 50% and NII is 15%. The price band is fixed at ₹71 to ₹72 per equity share.

Striders Impex IPO

The Striders Impex IPO minimum market lot is 3200 shares with ₹2,30,400 application amount. The Striders Impex IPO is an SME IPO, and it is to be listed on the NSE.

Business Overview

Striders Impex Limited is one of the leading companies was founded in 2021. The company has started a business of licensing, own brand development, and distribution of toys and kids’ consumer merchandise.  

The company provides complete solutions, from designing and making products to sourcing, manufacturing, and distributing them, serving stores across India and some international markets.  

In India, the company aims to expand its retail reach in more cities while continuing to supply premium stores like Timezone and Landmark. 


IPOWatch View

We recommend that investors apply for an IPO with Long-term Views. Investors should also look at the QIB, NII, and Retail numbers before investing.

Striders Impex IPO Subscription Status – Day 1

CategoryDay 1Day 2Day 3
QIB0.000.000.00
NII0.000.000.00
RII0.010.000.00
Total0.000.000.00


Striders Impex IPO Investor Categories

  • Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds
  • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
  • Retail Individual Investors (RII): Retail Individual Investors or NRIs
  • Employee (EMP): Eligible Employees
  • Others: Eligible Shareholders

Striders Impex IPO Review and Rating

  • Neutral

Striders Impex IPO Form

How to apply for the Striders Impex IPO? You can apply for Striders Impex IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Striders Impex IPO in the Invest section. The other option is you can apply for Striders Impex IPO via IPO forms downloaded online. Check out the Asston Pharmaceuticals forms – Click IPO Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Striders Impex IPO Subscription Status FAQs:


When Striders Impex IPO Subscription will start?

The IPO subscription starts on February 26, 2026 for QIB, NII, and Retail Investors.

How to subscribe Striders Impex IPO?

You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

How do I check live Striders Impex IPO Subscription Numbers Today?

One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official websites. One can check the live subscription on official websites on the particular IPO page.

How to Apply the Striders Impex IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Striders Impex IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Striders Impex IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals ” Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *